Stanford University School of Medicine
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Stanford University School of Medicine
Athenex expands its portfolio of T-cell receptor therapy technology under NCI license agreement; PDS Biotechnology accesses institute’s TARP tumor antigen technology.
$47.5m partnership between the foundation and Broad researchers will mine genetic data for insights into disease mechanisms. MD Anderson, Nuvectis each unveil multiple new tie-ups.
The firms hope academic research can yield first-in-class therapies and spinout companies. Also, Yale unveils research alliances with three biotechs.
Vitamin Shoppe’s True Athlete line enters the sports nutrition ring; Metagenics makes “smart multi”; antacid supplement features ProDigestive enzymes; Wellesse targets bariatric surgery patients; C3* drink tackles stress; more New Products In Brief.
- Academic and Research Institutions
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.